(3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide
C21H25N9O — CID 121452493
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide
(3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide (PubChem CID 121452493) has the molecular formula C21H25N9O and a molecular weight of 419.49 g/mol. Its IUPAC name is (3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide.
Molecular Properties
| Compound Name | (3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide |
|---|---|
| PubChem CID | 121452493 |
| Molecular Formula | C21H25N9O |
| Molecular Weight | 419.49 g/mol |
| Exact Mass | 419.22 |
| IUPAC Name | (3S)-4-(6-amino-1-methylpyrazolo[5,4-d]pyrimidin-4-yl)-3-methyl-N-(1-methylindol-4-yl)piperazine-1-carboxamide |
| SMILES | C[C@H]1CN(C(=O)Nc2cccc3c2ccn3C)CCN1c1nc(N)nc2c1cnn2C |
| InChI | InChI=1S/C21H25N9O/c1-13-12-29(21(31)24-16-5-4-6-17-14(16)7-8-27(17)2)9-10-30(13)19-15-11-23-28(3)18(15)25-20(22)26-19/h4-8,11,13H,9-10,12H2,1-3H3,(H,24,31)(H2,22,25,26)/t13-/m0/s1 |
| InChIKey | SSYIPZRXWQXQHK-ZDUSSCGKSA-N |
| XLogP | 2.18 |
| TPSA | 110.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.49 |
| LogP ≤ 5 | 2.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121452493 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.